0000950123-11-018461 Sample Contracts

SEVENTH AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT

Loan and Security Agreement • February 25th, 2011 • Impax Laboratories Inc • Pharmaceutical preparations • Pennsylvania

• Contract Type
  Loan and Security Agreement
• Filed
  February 25th, 2011
• Company
  Impax Laboratories Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Pennsylvania

THIS SEVENTH AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (the “Amendment”) is made effective as of the 31st day of January, 2011, by and between IMPAX LABORATORIES, INC., a Delaware corporation (“Borrower”), and WELLS FARGO BANK, NATIONAL ASSOCIATION successor by merger to WACHOVIA BANK, NATIONAL ASSOCIATION (together with its successors and assigns, “Bank”).

LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT

License, Development and Commercialization Agreement • February 25th, 2011 • Impax Laboratories Inc • Pharmaceutical preparations • Delaware

• Contract Type
  License, Development and Commercialization Agreement
• Filed
  February 25th, 2011
• Company
  Impax Laboratories Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (the “Agreement”) is entered into as of December 15, 2010 (the “Effective Date”) by and between IMPAX LABORATORIES, INC., a Delaware corporation with its principal place of business at 30831 Huntwood Avenue, Hayward, CA 94544 (“Impax”), and GLAXO GROUP LIMITED, a company organized and existing under the laws of England and having an office and place of business at Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, UB6 ONN, United Kingdom (“GSK”). Impax and GSK are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”

SUPPLY AGREEMENT

Supply Agreement • February 25th, 2011 • Impax Laboratories Inc • Pharmaceutical preparations • Delaware

• Contract Type
  Supply Agreement
• Filed
  February 25th, 2011
• Company
  Impax Laboratories Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Supply Agreement (the “Supply Agreement”) is entered into as of December 15, 2010 (the “Effective Date”) by and between Impax Laboratories, Inc., a Delaware corporation with its principal place of business at 30831 Huntwood Avenue, Hayward, CA 94544 (“Impax”), and Glaxo Group Limited, doing business as GlaxoSmithKline, a company organized and existing under the laws of England and having an office and place of business at Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, UB6 ONN, United Kingdom (“GSK”). Impax and GSK are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.